Joincare Pharmaceutical Group Industry Co Ltd Capital Reinvestment Ratio
Joincare Pharmaceutical Group Industry Co Ltd capital reinvestment ratio. Joincare Pharmaceutical Group Industry Co Ltd (600380) has a Capital Reinvestment Ratio of 0.14x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥1.09 Billion) in capital expenditures (CN¥155.85 Million). Check 600380 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Joincare Pharmaceutical Group Industry Co Ltd (1999–2025)
Capital reinvestment ratio of Joincare Pharmaceutical Group Industry Co Ltd from 1999 to 2025. This chart tracks Joincare Pharmaceutical Group Industry Co Ltd's Capital Reinvestment Ratio across 27 annual periods. Also explore 600380 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Joincare Pharmaceutical Group Industry Co Ltd Capital Reinvestment Ratio by Year (1999–2025)
Joincare Pharmaceutical Group Industry Co Ltd capital reinvestment ratio by year from 1999 to 2025. For the full cash flow conversion analysis, see cash flow conversion of Joincare Pharmaceutical Group Industry C.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.20x | CN¥3.89 Billion | CN¥767.20 Million | ▼ -26.8% |
| 2024 | 0.27x | CN¥3.64 Billion | CN¥979.13 Million | ▼ -6.4% |
| 2023 | 0.29x | CN¥3.93 Billion | CN¥1.13 Billion | ▼ -0.3% |
| 2022 | 0.29x | CN¥3.98 Billion | CN¥1.15 Billion | ▼ -51.4% |
| 2021 | 0.59x | CN¥2.56 Billion | CN¥1.52 Billion | ▲ +116.2% |
| 2020 | 0.27x | CN¥3.02 Billion | CN¥830.41 Million | ▼ -9.7% |
| 2019 | 0.30x | CN¥2.31 Billion | CN¥703.20 Million | ▼ -15.2% |
| 2018 | 0.36x | CN¥1.83 Billion | CN¥655.02 Million | ▲ +39.6% |
| 2017 | 0.26x | CN¥1.87 Billion | CN¥480.68 Million | ▼ -15.5% |
| 2016 | 0.30x | CN¥1.64 Billion | CN¥499.99 Million | ▼ -35.3% |
| 2015 | 0.47x | CN¥1.26 Billion | CN¥594.33 Million | ▼ -43.7% |
| 2014 | 0.83x | CN¥979.46 Million | CN¥816.97 Million | ▼ -46.1% |
| 2013 | 1.55x | CN¥635.52 Million | CN¥983.83 Million | ▲ +31.7% |
| 2012 | 1.18x | CN¥734.36 Million | CN¥863.48 Million | ▲ +73.8% |
| 2011 | 0.68x | CN¥650.36 Million | CN¥440.12 Million | ▲ +28.0% |
| 2010 | 0.53x | CN¥1.11 Billion | CN¥584.47 Million | ▲ +4.4% |
| 2009 | 0.51x | CN¥605.66 Million | CN¥306.87 Million | ▲ +5.9% |
| 2008 | 0.48x | CN¥455.01 Million | CN¥217.71 Million | ▼ -16.7% |
| 2007 | 0.57x | CN¥429.26 Million | CN¥246.63 Million | ▼ -68.1% |
| 2006 | 1.80x | CN¥272.50 Million | CN¥490.19 Million | ▲ +77.6% |
| 2005 | 1.01x | CN¥363.13 Million | CN¥367.73 Million | ▲ +11.3% |
| 2004 | 0.91x | CN¥241.71 Million | CN¥219.90 Million | ▲ +41.7% |
| 2003 | 0.64x | CN¥172.25 Million | CN¥110.60 Million | ▲ +64.6% |
| 2002 | 0.39x | CN¥236.13 Million | CN¥92.09 Million | ▲ +25.5% |
| 2001 | 0.31x | CN¥223.79 Million | CN¥69.55 Million | ▼ -23.2% |
| 2000 | 0.40x | CN¥171.61 Million | CN¥69.46 Million | ▼ -9.6% |
| 1999 | 0.45x | CN¥109.82 Million | CN¥49.15 Million | — |